Efficacy and safety of behavioural activation on depression in people with co-occurring non-communicable diseases: systematic review and meta-analysis.

ABSTRACT:

Background

People with non-communicable diseases (NCDs) have a higher prevalence of comorbid depression than the general population. While previous research has shown that behavioural activation is effective for general depression, its efficacy and safety in treating depression associated with NCDs remains unclear.

Aims

To compare the efficacy and safety of behavioural activation against comparators in reducing depression symptoms in people with NCDs.

Method

We searched six databases from inception until 30 March 2023 (updated 23 September 2024) for randomised controlled trials (RCTs) comparing behavioural activation with comparators for depression in people with NCDs. Risk of bias was assessed using the Cochrane Collaboration's 'risk-of-bias 2 tool'. We calculated a

SUBMITTER: Yisma E 

PROVIDER: S-EPMC12021889 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature